(May 20, 2016, 12:40 PM EDT) -- DALLAS — A Texas federal judge on May 18 denied a whistle-blower’s motion for a new trial in his False Claims Act case alleging that Abbott Laboratories Inc. promoted its biliary stents for off-label use in the vascular system (United States of America, ex rel. Kevin Colquitt v. Abbott Laboratories, et al., No. 06-1769, N.D. Texas)....